Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/9c5c78d5-7759-40ff-a0d6-0809ff01460f/

IPCALAB

Ipca Laboratories Limited
Chart
₹1,641.90
Latest Week 2026-06-05
HealthcareDrug Manufacturers - Specialty & GenericMEGA
Snapshot 2026-06-07 · 0.0w · Fresh
0.62
OS Score
20.0%
Value
94.0%
Quality
83.0%
Momentum
9/9
F-Score
0.434
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
0 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
20.0%ile
P/E
36.5×
P/S
4.3×
P/B
5.2×
E/P
0.0274
FCF Yield
0.012
EBITDA/EV
0.049
SH Yield
0.001
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
82.00000000
/100 — 1=cheapest
VC2 (Trending Value)
79.00000000
/100
VC3 (Buyback)
75.00000000
/100
P/E of 36.5x is premium-priced — the market is paying up for expected growth.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
94.0%ile
ROE
0.142
ROA
0.092
Net Margin
0.118
Op Margin
0.162
GPA
0.552
Current
2.76
F-Score
9/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.079
Earn Growth
0.547
Stability
0.426
lower=better
Accruals
0.000
lower=better
5yr Consist
No
F-Score of 9/9 indicates strong fundamental improvement across multiple dimensions.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
83.0%ile
6M Return
12.5%
12M Return
19.9%
12-1 Mom
13.4%
Risk-Adj
0.43
Vol 252d
30.9%
Vol 60d
72.8%
↑ Expanding
Max DD 12M
-15.8%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (73%) is expanding vs long-term (31%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.62
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 160 peers
Sector Value %ile
39.8%
Sector Quality %ile
90.1%
P/E z-score
-0.17
P/B z-score
-0.07
Sector Avg OS
43.6%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
NATCOPHARM NATCO Pharma Limited 98.0% 88.0% 87.0% 81.0%
UNIVPHOTO Universus Photo Imagings Limited 97.0% 86.0% 74.0% 94.0%
LINCOLN Lincoln Pharmaceuticals Limited 97.0% 88.0% 80.0% 81.0%
STAR Strides Pharma Science Limited 96.0% 73.0% 91.0% 91.0%
VENUSREM Venus Remedies Limited 96.0% 68.0% 94.0% 99.0%
HALEOSLABS Haleos Labs Limited 95.0% 82.0% 77.0% 81.0%
AUROPHARMA Aurobindo Pharma Limited 94.0% 71.0% 84.0% 87.0%
SAGILITY Sagility Limited 93.0% 76.0% 81.0% 76.0%
Factor Interactions
Quality Momentum — Expensive
Strong quality (94th) and momentum (83th) but expensive (20th value). Premium priced — watch for mean reversion.
Quality at a Premium
High quality (94th) but expensive (20th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (73%) significantly exceeds 252-day (31%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
D
31.2% avg (7 factors)
Quality
B
64.8% avg (7 factors)
Momentum
C
48.9% avg (4 factors)
Risk
B
65.1% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.620—0—
Value %ile0.200—1—
Quality %ile0.940—1—
Momentum %ile0.830—1—
F-Score9.000—1—
Confidence0.939—1—
Volatility0.309—0—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
36.50
Earnings Yield (E/P)
0.0274
Price / Sales
4.32
Price / Book
5.17
Price / Cash Flow
36.48
FCF Yield
1.2%
EBITDA / EV
4.9%
Sales Yield (1/P·S)
0.2295
Shareholder Yield
Div + net buyback / mktcap
0.1%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
14.2%
Return on Assets
9.2%
Net Margin
11.8%
Operating Margin
16.2%
Gross Profit / Assets
Novy-Marx GPA
55.2%
Current Ratio
2.76
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.000
MomentumPrice trend strength over different horizons
6M Return
12.5%
12M Return
19.9%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
13.4%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.43
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
7.9%
Earnings Growth (YoY)
54.7%
Earnings Stability (CV)
Lower = more stable
0.426
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
9
Dividend Yield
0.1%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
82
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
79
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
75
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity